Erie Retinal Surgery is a clinical research site located in Erie, Pennsylvania, United States 16507.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Erie Retinal Surgery has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Age-Related Macular Degeneration, Proliferative Diabetic Retinopathy, Diabetic Macular Edema.
Sponsors: Genentech, Inc., Novartis Pharmaceuticals, Hoffmann-La Roche.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Erie Retinal Surgery has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Erie Retinal Surgery has 6 clinical trials on record, with 3 currently active. Their work covers Age-Related Macular Degeneration, Proliferative Diabetic Retinopathy, Diabetic Macular Edema.
Yes — Erie Retinal Surgery holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.